LMDP10 is an orally active 3-aminoquinazoline derivative that activates the Keap1-Nrf2 pathway. It binds to Keap1, inhibiting the Keap1-Nrf2 interaction and subsequently activating the Nrf2 pathway. This leads to increased levels of Nrf2, SOD, and GSH, while reducing MDA and TNF-alpha levels. As a result, LMDP10 alleviates neurodegeneration and improves memory in Alzheimers disease (AD) rat models. LMDP10 is applicable for Alzheimers disease (AD) research.
Molekulargewicht:
492.51
CAS Nummer:
[2760446-25-9]
Formel:
C29H21FN4O3
Target-Kategorie:
Nrf2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten